Physician

Douglas Stewart Mehr, M.D.

According to 2025 Medicare claims, Douglas Mehr, M.D. (NPI: 1720070899) practices ophthalmology in the Salt Lake City-Murray, UT market, with the plurality of this provider's patient population coming from Salt Lake, UT. This provider's primary affiliated billing organization is SALT LAKE RETINA, LLC (NPI: 1144622234; TIN: 47-1293676) and primary practice location at 84088-5561.

Mehr's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 588 traditional Medicare patients, billed 55,751 HCPCS/CPT codes, and received $3,384,662 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 1,079 prescription claims across 393 beneficiaries totaling $21,963 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 23 records totaling $580. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $1,485,107 to $3,384,662. In contrast, Part D prescription costs have declined steadily, from $31,506 to $21,963. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.7M$3.4M2015 Medicare payment: $1,485,107 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,254,179 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,128,905 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,294,651 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,570,665 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,787,900 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,716,116 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,757,697 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,781,933 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,384,662 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155118,441$1,485,107
20164457,120$1,254,179
20174646,731$1,128,905
20184997,109$1,294,651
20195468,569$1,570,665
20205589,145$1,787,900
20215258,984$1,716,116
202256016,830$1,757,697
202361545,242$2,781,933
202458855,751$3,384,662

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$17K$35K2015 Drug cost: $31,506 (USD; Tot_Drug_Cst)2016 Drug cost: $30,250 (USD; Tot_Drug_Cst)2017 Drug cost: $33,641 (USD; Tot_Drug_Cst)2018 Drug cost: $33,805 (USD; Tot_Drug_Cst)2019 Drug cost: $29,715 (USD; Tot_Drug_Cst)2020 Drug cost: $34,745 (USD; Tot_Drug_Cst)2021 Drug cost: $24,758 (USD; Tot_Drug_Cst)2022 Drug cost: $21,608 (USD; Tot_Drug_Cst)2023 Drug cost: $28,929 (USD; Tot_Drug_Cst)2024 Drug cost: $21,963 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015228593$31,506
2016217548$30,250
2017224552$33,641
2018252608$33,805
2019259614$29,715
2020295808$34,745
2021307754$24,758
2022342871$21,608
20234361,062$28,929
20243931,079$21,963

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92235Exam of retinal blood vessels using a special camera after injection of a dye129135$112
67028Injection of drug into eye2621,726$93
92014Established patient complete exam of visual system352499$78
92134Imaging of retina4481,815$29
92250Photography of the retina195211$24

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1203,202$4,702
Diclofenac SodiumDiclofenac Sodium3417,609$3,911
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat23614,726$3,066
LatanoprostLatanoprost1197,528$1,278
MoxifloxacinMoxifloxacin Hcl54821$1,202

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.23$580Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Douglas Stewart Mehr, M.D.?

Tedicare shows public-source Medicare data for Douglas Stewart Mehr, M.D. (NPI 1720070899), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Douglas Stewart Mehr, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Douglas Stewart Mehr, M.D.?

Douglas Stewart Mehr, M.D. is linked to SALT LAKE RETINA, LLC (billing NPI 1144622234) in the available physician profile data.

Does Douglas Stewart Mehr, M.D. have Open Payments data?

Douglas Stewart Mehr, M.D. has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.